A Phase IV Study to Evaluate the Immunogenicity and Safety in UK Laboratory Workers of Menitorix

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 31, 2007

Study Completion Date

August 31, 2007

Conditions

Vaccination

Interventions

BIOLOGICAL

Menitorix (MenC and Hib conjugate)

Trial Locations (1)

Health Protection Agency, Manchester Laboratory., Manchester

All Listed Sponsors

lead

Public Health England

OTHER_GOV

NCT00503165 - A Phase IV Study to Evaluate the Immunogenicity and Safety in UK Laboratory Workers of Menitorix | Biotech Hunter | Biotech Hunter